MedPath

A Prospective Study Investigating the Impact of Definitive Chemoradiation in Locally and/or Regionally Advanced Squamous Cell Carcinoma of the Ski

Phase 2
Completed
Conditions
Squamous Cell Carcinoma of the Skin
Cancer - Other cancer types
Registration Number
ACTRN12607000534482
Lead Sponsor
Michelle Nottage
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
30
Inclusion Criteria

Patients with cutaneous squamous cell carcinoma with locally-advanced disease at the primary site +/-nodal metastases, or advanced regional node metastases of presumed skin origin.
Disease deemed unsuitable for surgical resection

Exclusion Criteria

Co-morbid conditions precluding safe administration of trial therapy
Previous chemo- or radiotherapy to head and neck region precluding re-treatment
Pregnancy/lactation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Complete Response Rate[8weeks after completion of therapy]
Secondary Outcome Measures
NameTimeMethod
Overall Survival[3years];Disease-free Survival[3years];Toxicity according to Common Toxicity Criteria Version 3.0[Acute toxicity monitored daily for the 7 weeks of radiation therapy, then at 4,8 & 12 weeks after completion of therapy. Late toxicity monitored every 2months for first year and every 3rd month for thereafter]
© Copyright 2025. All Rights Reserved by MedPath